Entropy Technologies »

Theravance Biopharma shares owned by Entropy Technologies

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Entropy Technologies from 13F filings

Historical chart of Entropy Technologies investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Entropy Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Entropy Technologies

Quarter filed Position value Share count Share price at filing
2025-12-31 $222k 12k 18.71

More positions owned by Entropy Technologies

Palantir Technologies Cl A Ord Cl A (PLTR)
Exxon Mobil Corporation (XOM)
Micron Technology (MU)
Servicenow (NOW)
Netflix (NFLX)
Citigroup Ord Com New (C)
Abbott Laboratories (ABT)
ConocoPhillips (COP)
Eaton Ord SHS (ETN)
Boston Scientific Corporation (BSX)
Adobe Systems Incorporated (ADBE)
Procter & Gamble Company (PG)
Trane Technologies Ord SHS (TT)
American Tower Reit (AMT)
Stryker Corporation (SYK)

View all positions for Entropy Technologies

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
Park West Asset Management
D. E. Shaw & Co
Acadian Asset Management
State Street Corporation
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Dimensional Fund Advisors
Oasis Management
UBS Group

View all funds holding Theravance Biopharma